Hemophilia A and B

The Hemophilia A and B pipeline: 2 tracked drugs, 1 approved for this indication.

Coverage in progress. The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Hemophilia A and B, so this list is not complete.

1 approved / phase 41 preclinical / unstaged

Compare the share prices of listed companies in Hemophilia A and B →

Market size not yet sourced. How markets are sized ↗

The Hemophilia A and B pipeline

← all assets